CRISM Therapeutics LTD
1 clinical trials · Sponsor
◉ Watch CRISM Therapeutics LTD
| Record | Firm | Date |
|---|---|---|
| Irinotecan-ChemoSeed in Surgically Resectable Glioblastoma (NCT07356973) | CRISM Therapeutics LTD | 2026-03-01 |
Track CRISM Therapeutics LTD automatically
Every clearance here is in the API, with alerts when new ones post.